Figure 4.
OS in R/R CLL with acalabrutinib monotherapy for del(17p)/TP53m, uIGHV, or CK.

OS in R/R CLL with acalabrutinib monotherapy for del(17p)/TP53m, uIGHV, or CK.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal